Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$20.77
-0.90-4.15%
At close: -
$20.77
0.000.00%
After Hours: May 23, 4:00 PM EDT
Comments
Loading...
AMN Healthcare Services Analyst Ratings and Price Targets | NYSE:AMN | Benzinga
AMN Healthcare Services Inc has a consensus price target of $56.25 based on the ratings of 12 analysts. The high is $121 issued by Credit Suisse on June 16, 2022. The low is $25 issued by Truist Securities on April 15, 2025. The 3 most-recent analyst ratings were released by UBS, Truist Securities, and BMO Capital on May 13, 2025, April 15, 2025, and February 24, 2025, respectively. With an average price target of $27.83 between UBS, Truist Securities, and BMO Capital, there's an implied 34.01% upside for AMN Healthcare Services Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Truist Securities
BMO Capital
Citizens Capital Markets
JMP Securities
1calculated from analyst ratings
Analyst Ratings for AMN Healthcare Services
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2025 | Buy Now | 22.77% | UBS | A.J. Rice70% | $30 → $25.5 | Maintains | Neutral | Get Alert |
| 04/15/2025 | Buy Now | 20.37% | Truist Securities | Tobey Sommer73% | $40 → $25 | Maintains | Buy | Get Alert |
| 02/24/2025 | Buy Now | 58.88% | BMO Capital | Jeffrey Silber75% | $38 → $33 | Maintains | Outperform | Get Alert |
| 02/24/2025 | Buy Now | 58.88% | Citizens Capital Markets | Constantine Davides41% | $34 → $33 | Maintains | Market Outperform | Get Alert |
| 02/21/2025 | Buy Now | 92.59% | Truist Securities | Tobey Sommer73% | $47 → $40 | Maintains | Buy | Get Alert |
| 02/06/2025 | Buy Now | 63.7% | JMP Securities | Constantine Davides41% | $34 → $34 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/13/2024 | Buy Now | 30% | Jefferies | Brian Tanquilut46% | $41 → $27 | Maintains | Hold | Get Alert |
| 11/11/2024 | Buy Now | 121.47% | BMO Capital | Jeffrey Silber75% | $50 → $46 | Maintains | Outperform | Get Alert |
| 11/08/2024 | Buy Now | 126.29% | Truist Securities | Tobey Sommer73% | $50 → $47 | Maintains | Buy | Get Alert |
| 11/08/2024 | Buy Now | — | William Blair | Tim Mulrooney62% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/22/2024 | Buy Now | 174.43% | JMP Securities | Constantine Davides41% | $66 → $57 | Maintains | Market Outperform | Get Alert |
| 10/21/2024 | Buy Now | 140.73% | Truist Securities | Tobey Sommer73% | $70 → $50 | Maintains | Buy | Get Alert |
| 10/07/2024 | Buy Now | 131.1% | B of A Securities | Kevin Fischbeck67% | $65 → $48 | Downgrade | Neutral → Underperform | Get Alert |
| 10/04/2024 | Buy Now | 217.77% | JMP Securities | Constantine Davides41% | $66 → $66 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/02/2024 | Buy Now | — | Benchmark | Bill Sutherland68% | — | Reiterates | → Hold | Get Alert |
| 08/13/2024 | Buy Now | 217.77% | JMP Securities | Constantine Davides41% | $75 → $66 | Maintains | Market Outperform | Get Alert |
| 08/12/2024 | Buy Now | 241.84% | BMO Capital | Jeffrey Silber75% | $60 → $71 | Maintains | Outperform | Get Alert |
| 08/09/2024 | Buy Now | 212.95% | UBS | A.J. Rice70% | $66 → $65 | Maintains | Neutral | Get Alert |
| 05/28/2024 | Buy Now | — | Benchmark | Bill Sutherland68% | — | Reiterates | → Hold | Get Alert |
| 05/15/2024 | Buy Now | 212.95% | B of A Securities | Kevin Fischbeck67% | $61 → $65 | Maintains | Neutral | Get Alert |
| 05/13/2024 | Buy Now | 241.84% | BMO Capital | Jeffrey Silber75% | $80 → $71 | Maintains | Outperform | Get Alert |
| 05/10/2024 | Buy Now | 261.1% | JMP Securities | Constantine Davides41% | $75 → $75 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/02/2024 | Buy Now | — | Benchmark | Bill Sutherland68% | — | Reiterates | → Hold | Get Alert |
| 04/22/2024 | Buy Now | 237.02% | Truist Securities | Tobey Sommer73% | $88 → $70 | Maintains | Buy | Get Alert |
| 02/26/2024 | Buy Now | 261.1% | JMP Securities | Constantine Davides41% | $87 → $75 | Maintains | Market Outperform | Get Alert |
| 02/20/2024 | Buy Now | 299.61% | BMO Capital | Jeffrey Silber75% | $85 → $83 | Maintains | Outperform | Get Alert |
| 02/16/2024 | Buy Now | 318.87% | JMP Securities | Constantine Davides41% | $92 → $87 | Maintains | Market Outperform | Get Alert |
| 12/06/2023 | Buy Now | 309.24% | JMP Securities | Constantine Davides41% | → $85 | Initiates | → Market Outperform | Get Alert |
| 12/05/2023 | Buy Now | 323.69% | Truist Securities | Tobey Sommer73% | → $88 | Reiterates | Buy → Buy | Get Alert |
| 11/30/2023 | Buy Now | 251.47% | UBS | A.J. Rice70% | → $73 | Initiates | → Neutral | Get Alert |
| 11/06/2023 | Buy Now | 323.69% | Truist Securities | Tobey Sommer73% | $95 → $88 | Maintains | Buy | Get Alert |
| 11/03/2023 | Buy Now | — | Benchmark | Bill Sutherland68% | — | Downgrade | Buy → Hold | Get Alert |
| 11/03/2023 | Buy Now | 237.02% | Jefferies | Brian Tanquilut46% | $115 → $70 | Downgrade | Buy → Hold | Get Alert |
| 08/07/2023 | Buy Now | 410.35% | BMO Capital | Jeffrey Silber75% | $114 → $106 | Maintains | Outperform | Get Alert |
| 08/04/2023 | Buy Now | 429.61% | Truist Securities | Tobey Sommer73% | $105 → $110 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | 405.54% | Credit Suisse | Jonathan Yong65% | $115 → $105 | Maintains | Outperform | Get Alert |
| 08/04/2023 | Buy Now | 400.72% | B of A Securities | Kevin Fischbeck67% | $112 → $104 | Downgrade | Buy → Neutral | Get Alert |
| 05/08/2023 | Buy Now | 371.83% | BMO Capital | Jeffrey Silber75% | $100 → $98 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 501.83% | Benchmark | Bill Sutherland68% | $135 → $125 | Maintains | Buy | Get Alert |
| 05/05/2023 | Buy Now | 453.68% | Credit Suisse | Jonathan Yong65% | $128 → $115 | Maintains | Outperform | Get Alert |
| 05/02/2023 | Buy Now | 405.54% | Truist Securities | Tobey Sommer73% | $140 → $105 | Maintains | Buy | Get Alert |
| 04/03/2023 | Buy Now | 516.27% | Credit Suisse | Jonathan Yong65% | $147 → $128 | Maintains | Outperform | Get Alert |
| 02/21/2023 | Buy Now | 424.8% | BMO Capital | Jeffrey Silber75% | $130 → $109 | Maintains | Outperform | Get Alert |
| 02/17/2023 | Buy Now | 607.75% | Credit Suisse | Jonathan Yong65% | → $147 | Reiterates | → Outperform | Get Alert |
| 02/17/2023 | Buy Now | 434.42% | Baird | Mark Marcon71% | $134 → $111 | Maintains | Neutral | Get Alert |
| 02/13/2023 | Buy Now | 612.57% | Benchmark | Bill Sutherland68% | → $148 | Reiterates | → Buy | Get Alert |
| 11/07/2022 | Buy Now | 525.9% | BMO Capital | Jeffrey Silber75% | $125 → $130 | Maintains | Outperform | Get Alert |
| 06/16/2022 | Buy Now | 482.57% | Credit Suisse | Nick Giovacchini49% | $120 → $121 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for AMN Healthcare Services (AMN) stock?
The latest price target for AMN Healthcare Services (NYSE:AMN) was reported by UBS on May 13, 2025. The analyst firm set a price target for $25.50 expecting AMN to rise to within 12 months (a possible 22.77% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for AMN Healthcare Services (AMN)?
The latest analyst rating for AMN Healthcare Services (NYSE:AMN) was provided by UBS, and AMN Healthcare Services maintained their neutral rating.
When was the last upgrade for AMN Healthcare Services (AMN)?
There is no last upgrade for AMN Healthcare Services
When was the last downgrade for AMN Healthcare Services (AMN)?
The last downgrade for AMN Healthcare Services Inc happened on November 8, 2024 when William Blair changed their price target from N/A to N/A for AMN Healthcare Services Inc.
When is the next analyst rating going to be posted or updated for AMN Healthcare Services (AMN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AMN Healthcare Services, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AMN Healthcare Services was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
Is the Analyst Rating AMN Healthcare Services (AMN) correct?
While ratings are subjective and will change, the latest AMN Healthcare Services (AMN) rating was a maintained with a price target of $30.00 to $25.50. The current price AMN Healthcare Services (AMN) is trading at is $20.77, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
